In a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP, the commonly used antidiabetic drug.
JALRA DP is a combination of Vildaglitpin 100mg SR (sustained release) & Dapagliflozin 10mg which was earlier costing Rs 25 per tablet or Rs 250 per strip will now be available at price of Rs 19.9 per tablet.
BDS, MDS( Pedodontics and Preventive Dentistry)